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genic role of KIPyV and WUPyV in 
immunocompromised patients.
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Extreme Drug  
Resistance in 
Acinetobacter  
baumannii  
Infections in  
Intensive Care 
Units, South Korea
To  the  Editor:  Acinetobacter 
spp.  have  emerged  as  a  cause  of 
nosocomial  infections,  especially  in 
intensive care units (ICUs). In South 
Korea, Acinetobacter spp. was ranked 
as  the  third  most  frequently  found 
pathogen in ICUs (1). With the emer-
gence  of  multidrug-resistant  (MDR) 
or  pandrug-resistant  (PDR)  isolates, 
few drugs are now available to treat 
MDR  or  PDR  Acinetobacter  infec-
tions; polymyxins are the only thera-
peutic option in many cases (2). Cur-
rent polymyxin resistance rates among 
Acinetobacter isolates are low world-
wide (3). We report the emergence of 
extreme drug resistance (XDR) in A. 
baumannii  isolates  from  patients  in 
ICUs of Samsung Medical Center in 
Seoul,  South  Korea.  These  isolates 
were resistant to all tested antimicro-
bial drugs, including polymyxin B and 
colistin,  to  which  PDR  isolates  are 
normally susceptible.
Sixty-three  nonduplicate  Acine-
tobacter spp. isolates were collected 
from the ICUs from April through No-
vember  2007.  Species  identification 
was performed based on partial RNA 
polymerase β-subunit gene sequences, 
amplified  rDNA  restriction  analysis, 
and the gyrase B gene–based multi-
plex PCR method (3). Forty-four iso-
lates were identified as A. baumannii: 
9 as genomic species 3, six as genomic 
species 13TU, 2 as A. baumannii-like 
species, and 1 each as A. junnii and ge-
nomic species 10.
In vitro susceptibility testing was 
performed and interpreted by using the 
broth microdilution method according 
to the Clinical and Laboratory Stan-
dards Institute guidelines (4). Colistin 
and polymyxin B resistances were de-
fined as MIC >4 mg/L (4). MDR was 
defined as characterized by resistance 
to >3 classes of antimicrobial drugs, 
and PDR was defined as characterized 
by resistance to all antimicrobial drugs, 
regardless of colistin and polymyxin 
B susceptibility. XDR was defined as 
resistance to all antimicrobial drugs. 
Multilocus  sequence  typing  (MLST) 
and  pulsed-field  gel  electrophoresis 
(PFGE) were performed for all PDR 
isolates  according  to  previously  de-
scribed methods (5,6). Genes encod-
ing oxacillinases, such as those classi-
fied as OXA-23-like, OXA-24/40-like, 
OXA-51-like, and OXA-58-like, were 
detected as previously described (7). 
PCR and sequence analyses were per-
formed to detect and characterize the 
other  antimicrobial  resistance  genes, 
according to methods reported (8).LETTERS
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Of  63  Acinetobacter  isolates, 
31.7%  and  34.9%  were  resistant  to 
imipenem  and  meropenem,  respec-
tively. Of the 63 isolates, 27.0% and 
30.2%  were  resistant  to  polymyxin 
B  and  colistin,  respectively.  For  the 
other  antimicrobial  drugs,  Acineto-
bacter spp. isolates showed antimicro-
bial resistance rates >50%. Nineteen 
isolates (30.2%), all belonging to A. 
baumannii, were PDR. Most of these 
PDR isolates (16/19, 84.2%) were col-
lected from endotracheal aspirate, and 
others were from peritoneal fluid and 
sputum. When characterized by PFGE 
and MLST, all PDR isolates belonged 
to a single clone, ST22, and all con-
tained the blaOXA-23 and blaOXA-66 genes.   
ISAba1  was  detected  upstream  of 
blaOXA-23 and blaOXA-66 in all PDR iso-
lates. In addition, most PDR isolates 
contained  blaTEM-116,  blaPER-1,  and 
blaADC-29 genes. TEM-116 is a point mu-
tant derivative of TEM-1, Val84→Ile. 
All β-lactamase genes were located on 
a plasmid. Also, ISAba1 was located 
at the upstream of all the blaADC, which 
was shown by PCR. However, none of 
the isolates had blaCTX-M, blaVEB, blaIMP, 
blaVIM, or blaGIM.
Of the PDR isolates, 8 were re-
sistant even to colistin and polymyxin 
B. These 8 isolates also showed resis-
tance to tigecycline (MICs 4 mg/L). 
Thus, they were resistant to all antimi-
crobial drugs tested in this study and 
were  considered  to  have  XDR.  The 
underlying  diseases  of  the  patients 
whose isolates were examined varied 
(Table). Although 2 isolates with XDR 
were colonizers, 6 caused infections. 
All but 1 patient was treated with me-
chanical  ventilation  before  isolation 
of the pathogen. Number of hospital 
days before isolation of A. baumannii 
was 13–256 days, and the number of 
ICU days before isolation was 2–38 
days.  Four  patients  were  immuno-
compromised, and 3 had bacteremia. 
Among  the  patients  with  infections 
characterized by XDR, the overall 30-
day mortality rate was 66.7%, and the 
infection-related 30-day mortality rate 
was 50.0%. All 8 isolates with XDR 
showed common characteristics: ST22 
containing OXA-23, OXA-66, TEM-
116, PER-1, and ADC-29.
We report the emergence of XDR 
in PDR A. baumannii isolates in South 
Korea.  Characteristics  of  PDR  A. 
baumannii isolates suggest that they 
spread from a single clone. A single 
A. baumannii strain with XDR might 
evolve  from  the  prevailing  PDR  A. 
baumannii  and  could  disseminate  in 
the ICU, probably after contamination 
of  the  hospital  environment  and  by 
nosocomial transmission. In South Ko-
rea, a high resistance rate to imipenem 
and meropenem in Acinetobacter spp. 
isolates may lead to extensive use of 
polymyxins (3). Thus, we can hypoth-
esize that the most prevalent carbap-
enem-resistant, or MDR A. baumannii 
clone, became PDR and then evolved 
into clones with XDR by acquisition 
of polymyxin resistance caused by an-
timicrobial pressure. Our investigation 
showed a simultaneous emergence of 
resistance to all antimicrobial agents 
available,  including  colistin,  poly-
myxin B, and tigecycline. XDR poses 
serious problems in the treatment of 
patients with A. baumannii infections, 
especially given the slow development 
of new antimicrobial agents. 
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Table. Clinical	characteristics	of	8	patients	infected	with	extremely	drug-resistant	Acinetobacter baumannii	isolates,	South	Korea*	
Days	before	isolation	
Strain	no.	
Patient
age/sex Underlying	disease	 Infection† Hospitalized In	ICU	
Concurrent		
bacteremia
30-d
outcome
Infection-
related	death
07AC–052 60	y/F	 Acute	myeloid	
leukemia
Pneumonia 15 8 No Died Yes 
07AC–159 79	y/M	 Lymphoma	 Pneumonia 35 9 No Died No
07AC–192 50	y/M	 Status	postliver	
transplantation
Pneumonia 256 2 Yes  Survived NA
07AC–204 55	y/F	 Steven-Johnson
syndrome	
Pneumonia 13 13 Yes  Survived NA
07AC–336 16	mo/M	 Medulloblastoma Pneumonia 32 13 Yes  Died Yes 
07AC–347 17	mo/M	 Hepatoblastoma	 Pneumonia 135 28 No Died Yes 
07AC–329 1	mo/F	 Edward	syndrome	 Colonization‡ 33 33 NA NA NA
07AC–063 56	y/M	 Lung cancer  Colonization‡ 26 21 NA NA NA
*ICU,	intensive	care	unit;	NA,	not	applicable.	All	but	1	patient	(with	strain	07AC–192)	had	mechanical	ventilators.	Four	patients	(with	strains	07AC–159,	
07AC–192,	07AC–336,	and	07AC–063)	were	immunocompromised	hosts	who	had	daily	administration	of	corticosteroid	(>20	mg/d	of	prednisolone	or	an	
equivalent	drug)	during	>2	wk	and	treatment	with	chemotherapy	for	an	underlying	malignancy	during	1	month	before	hospital	admission.	
†Infection	is	defined	as	invasion	of	the	body	tissues	by	microorganisms	resulting	in	disease.	
‡Colonization	occurs	when	an	agent’s	presence	in	a	host	does	not	cause	a	specific	immune	response	or	infection.	
1These	authors	contributed	equally	to	this	
article.LETTERS
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More Diseases 
Tracked by Using 
Google Trends 
To  the  Editor:  The  idea  that 
populations provide data on their in-
fluenza  status  through  information-
seeking behavior on the Web has been 
explored in the United States in recent 
years (1,2). Two reports showed that 
queries to the Internet search engines 
Yahoo and Google could be informa-
tive  for  influenza  surveillance  (2,3). 
Ginsberg  et  al.  scanned  the  Google 
database  and  found  that  the  sum  of 
the results of 45 queries that most cor-
related with influenza incidences pro-
vided the best predictor of influenza 
trends (3). On the basis of trends of 
Google queries, these authors put their 
results into practice by creating a Web 
page  dedicated  to  influenza  surveil-
lance. However, they did not develop 
the same approach for other diseases. 
To  date,  no  studies  have  been  pub-
lished about the relationship of search 
engine query data with other diseases 
or in languages other than English.
We compared search trends based 
on a list of Google queries related to 3 
infectious diseases (influenza-like ill-
ness, gastroenteritis, and chickenpox) 
with  clinical  surveillance  data  from 
the French Sentinel Network (4). Que-
ries  were  constructed  through  team 
brainstorming. Each participant listed 
queries likely to be used for searching 
information  about  these  diseases  on 
the Web. The query time series from 
January 2004 through February 2009 
for  France  were  downloaded  from 
Google Insights for Search, 1 of the 
2  websites  with  Google  Trends  that 
enables  downloading  search  trends 
from  the  Google  database  (5).  Cor-
relations with weekly incidence rates 
(no. cases/100,000 inhabitants) of the 
3  diseases  provided  by  the  Sentinel 
Network were calculated for different 
lag periods (Pearson coefficient ρ).
The  highest  correlation  with  in-
fluenza-like illness was obtained with 
the query grippe –aviaire –vaccin, the 
French  words  for  influenza,  avian, 
and  vaccine  respectively  (ρ  =  0.82, 
p<0.001).  The  minus  sign  removed 
queries  that  contained  the  terms  avi-
an or vaccine. Use of the query word 
grippe alone resulted in a lower cor-
relation (ρ = 0.34, p<0.001). The high 
double  peak  in  2005–2006  and  the 
smaller  peaks  preceding  annual  epi-
demics observed with the query word 
grippe  alone  were  decreased  by  this 
specification.  However,  the  unusual 
double-peak  shape  of  the  2005–2006 
epidemic  remained  (online Appendix 
Figure, panel A, available from www.
cdc.gov/EID/content/15/8/1327-appF.
htm).
The  highest  correlation  with 
acute diarrhea was obtained when we 
searched for the French word for gas-
troenteritis (ρ = 0.90, p<0.001). Vari-
ous spellings were used to account for 
the presence/absence of an accent or 
a hyphen. The Google database was 
searched for gastro-enterite + gastro-
entérite + gastroentérite + gastroenter-
ite + (gastro enterite) + (gastro enté-
rite). The + sign coded for or, enabling 
searches for queries containing >1 of 
the terms. The second highest correla-
tion was obtained when the keyword 
gastro (ρ = 0.88, p<0.001) (online Ap-
pendix Figure, panel B) was used. The 
highest  correlation  with  chickenpox 
was  obtained  with  the  French  word 
for chickenpox (varicelle) (ρ = 0.78, 
p<0.001)  (online  Appendix  Figure, 
panel C).
A time lag of 0 weeks gave the 
highest correlations between the best 